What This Series Is and Is Not: Applied Product Design for the TPA Market

LFP-15.PRE

#

The Genre Shift

#

Series 01 through 14 are analysis. They examine the architecture of level funded plans, the mechanics of stop loss underwriting, the regulatory environment that shapes the market, the employer segments that participate, the operational infrastructure that supports administration, the populations covered, the geographic variation that determines viability, the hybrid models emerging at the market’s frontier, the cost drivers that threaten sustainability, the cost management strategies that respond, the benefits design choices available, the AI forces disrupting operations, the technology gaps constraining TPAs, and the broker distribution channel that brings employers into the market. The reader of those series is a student of the market, drawing conclusions from evidence.

Series 15 is design. It proposes what to build.

The shift is deliberate. Analysis identifies problems and evaluates capabilities. Design responds with a product thesis. The reader of Series 15 is not learning what the market looks like. The reader is evaluating a product architecture that any TPA leadership team can apply to their own competitive position. The proposal builds directly on the preceding analysis, but the purpose changes. Series 15 answers a question the prior series do not ask: given everything established about how this market works, the design follows from the evidence.

What to Expect

#

The answer is a tiered product architecture. Three tiers, each designed for a distinct employer segment, each with a defined capability stack, each at a defined price point.

Core is standard level funded administration: claims adjudication, eligibility management, stop loss coordination, compliance documentation, employer reporting, network access, bundled ancillary options, member portal, and broker dashboard. This is table stakes. Every employer entering level funded needs these capabilities, and the TPA that executes them well builds the reputation that supports everything else.

Plus includes everything in Core plus active cost management as standard features: domestic facility steering to lower-cost alternatives, pharmacy optimization through a transparent PBM relationship, maternity management, MSK pathways including virtual physical therapy and surgical second opinions, chronic disease programs targeted by claims data identification, enhanced member navigation, and enhanced employer analytics. The critical design decision is that these programs are bundled as standard features, not sold as add-ons. They are standard because the savings they produce exceed the PMPM differential, making Plus self-funding for the employer who engages.

Black is the flagship. Everything in Plus, plus geographic arbitrage at scale: cross-border medical and dental care coordination through JCI-accredited international facilities, international pharmacy purchasing, social determinants of health integration, advanced chronic disease interception, mental health innovation with social isolation screening, GLP-1 management programs, full member concierge, predictive analytics, and a broker intelligence portal. For a mobile workforce that can receive care anywhere, Black turns that mobility into a cost advantage no geographically anchored plan can match.

The Structure

#

The series develops each tier (LFP-15.02, 15.03, 15.04), then addresses the cross-cutting product decisions. The classification logic (LFP-15.05) determines which services are risk-covered (included in the PMPM) versus priced as add-ons. The pricing article (LFP-15.06) establishes the PMPM economics for each tier. The technology article (LFP-15.07) identifies what Black requires that does not exist in the current TPA technology stack. Three distribution articles address the broker channel (LFP-15.08), the direct and digital channel (LFP-15.09), and the association and affinity channel (LFP-15.10). Go-to-market sequencing (LFP-15.11) addresses which tier first, which geography first, which segment first. Competitive moat (LFP-15.12) evaluates what makes the tiered model defensible.

The synthesis (LFP-15.SYN) assembles the complete product architecture. A TPA executive reading only the synthesis should understand the entire architecture and the logic behind it.

The companion (LFP-15.C1) argues the counterposition: that complexity kills in the small group market, that brokers cannot sell tiers, and that deepening a single core product may produce better commercial outcomes than tiering. The companion is not a straw man. The argument has merit for specific conditions, and the series engages it seriously.

Starting Position

#

The series addresses TPA leadership teams from multiple starting positions. The architecture described does not assume a single organizational profile. The reader should understand where their organization sits before evaluating what the architecture recommends.

The regional TPA with 3,000 to 8,000 covered lives, strong broker relationships in two or three states, and legacy technology faces a defined set of constraints. This operator can build Core and Plus from the existing administrative foundation. The technology work is extension, not replacement: adding care routing, enhanced analytics, and pharmacy optimization on top of platforms already in use. Black is a multi-year aspiration. The cross-border infrastructure, international pharmacy logistics, and concierge staffing model require capital and partnership development that may not be available in the near term. The correct sequence for this operator is Core first, demonstrating operational excellence within the current geography, then Plus once the cost management technology extensions are built and validated. Black enters the roadmap when the operational and capital conditions are met. The sequencing in LFP-15.11 applies directly to this profile.

The national independent TPA with 15,000 to 50,000 covered lives, multiple stop loss carrier relationships, and modern-ish technology has the scale to build the full tier stack. The organizational challenge is not capability but execution discipline. Running three products simultaneously without cannibalization requires clear tier boundaries, tier-specific broker training, and operational processes that route employers to the right product without confusion. The risk for this operator is overextension: announcing all three tiers before the Plus and Black infrastructure is ready. The go-to-market sequence matters as much at national scale as at regional scale. The larger book generates the data volume that Black analytics require, which is an advantage. The organizational change management of running three simultaneous product lines is the constraint.

The startup or insurtech entrant with capital and purpose-built technology but no book of business faces an inverted problem. Building Black first and working backward to Core is technically possible when the technology is modern and the target market is high-income employers who appreciate the Black capability stack. The distribution challenge is acquiring the first Core and Plus accounts that generate the claims data Black analytics require. An insurtech that builds Black infrastructure but cannot generate sufficient data to validate the predictive models has built a capability without a foundation. The go-to-market sequence for this operator may be Black-first for distribution purposes, anchored in a high-income employer segment, while building the Core and Plus book in parallel to generate the data that makes Black analytics increasingly valid.

The carrier-affiliated TPA with distribution advantages and technology constraints faces the most constrained version of this decision. The carrier’s product strategy determines the TPA’s room to maneuver. If the carrier’s small group strategy is fully insured, the TPA’s tiered level funded model competes with the carrier’s own product. If the carrier supports level funded, the TPA’s tier design must fit within the carrier’s distribution and underwriting infrastructure. The carrier-affiliated TPA should evaluate whether tiering is feasible within their organizational structure before committing to the architecture. A tiered model that the carrier will not actively support through its distribution relationships is a design problem, not just a technology problem. LFP-15.C1 addresses the conditions under which the single-product approach is the better answer.

What This Is Not

#

This is not neutral analysis of the TPA market. It is a product thesis built from evidence assembled across fourteen preceding series and applied to a design question that evidence raises. The evidence base is the same as the preceding series. The regulatory analysis from Series 03, the employer segmentation from Series 04, the population data from Series 06, the cost management strategies from Series 10, the technology assessment from Series 13, and the broker capability analysis from Series 14 all feed directly into the design decisions that follow. Every assertion in Series 15 traces back to evidence established elsewhere in the project.

The publication serves the market by making the design logic explicit. Any TPA reading this series can evaluate whether the tiered model applies to their own positioning. Any broker reading it can understand what a tiered product architecture looks like and why it changes the sales conversation. Any employer reading it can evaluate whether the architecture serves their needs. The transparency is intentional. The reader should understand what they are reading: design, not commentary.

Whatever the starting position, the series describes the architecture. The sequencing article (LFP-15.11) addresses how starting position affects go-to-market order. This preface establishes that the architecture is addressed to the market, not to any single operator, and that the reader’s task is to identify where their organization’s starting position intersects with what the architecture proposes.

What follows is applied.